Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine

Pharmacogenomics of Methotrexate Pathway in Rheumatoid Arthritis Patients: Approach toward Personalized Medicine

Background: Methotrexate (MTX) is one of the most common medications used for rheumatoid arthritis (RA) treatment. Single-nucleotide polymorphisms (SNPs) could potentially predict variability in therapeutic outcomes. Aim: This study aims to assess the impact of SNPs in genes encoding for the MTX pat...

Full description

Bibliographic Details
Main Authors: Hoda Y. Abdallah, Maha E. Ibrahim, Noha M. Abd El-Fadeal, Dina A. Ali, Gehad G. Elsehrawy, Rasha E. Badr, Howayda M. Hassoba
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Diagnostics
Subjects:
rheumatoid arthritis
allelic discrimination
genotyping
methotrexate
single-nucleotide polymorphism
ATIC
Online Access:https://www.mdpi.com/2075-4418/12/7/1560

Internet

https://www.mdpi.com/2075-4418/12/7/1560

Similar Items